CLIF-C ACLF (Acute-on-Chronic Liver Failure)
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۰۰ • واحد: years
حداقل ۰.۱ — حداکثر ۱۰۰ • واحد: ×10⁹ cells/L
حداقل ۰.۱ — حداکثر ۵۰ • واحد: mg/dL
حداقل ۰.۱ — حداکثر ۲۰ • واحد: mg/dL
حداقل ۰.۵ — حداکثر ۱۰
حداقل ۳۰ — حداکثر ۱۵۰ • واحد: mmHg
حداقل ۵۰ — حداکثر ۶۰۰
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–45
- Moderate Risk45–65
- High Risk65–70
- Critical Risk70–100
The CLIF-C ACLF (Acute-on-Chronic Liver Failure) calculates predicting mortality in acute-on-chronic liver failure patients. Key inputs include age. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts mortality in acute-on-chronic liver failure patients
Clinical Indication
The CLIF-C ACLF (Acute-on-Chronic Liver Failure) is indicated for bedside clinical practice to support Predicts mortality in acute-on-chronic liver failure patients. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: Should be used in conjunction with clinical judgment for treatment decisions.
CLIF-C ACLF Score = 10 × [0.33 × CLIF-C OF Score + 0.04 × age + 0.63 × ln(WBC count) - 2]. CLIF-C OF Score based on 6 organ systems: liver (bilirubin), kidney (creatinine/RRT), brain (hepatic encephalopathy), coagulation (INR), circulatory (MAP/vasopressors), respiratory (PaO2/FiO2 or SpO2/FiO2).
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient age in years(years) |
| white_blood_cell_count | float | Yes | White blood cell count(×10⁹ cells/L) |
| bilirubin | float | Yes | Total bilirubin level(mg/dL) |
| creatinine | float | Yes | Serum creatinine level(mg/dL) |
| renal_replacement_therapy | string | Yes | Patient on renal replacement therapy |
| hepatic_encephalopathy_grade | string | Yes | Hepatic encephalopathy grade |
| inr | float | Yes | International normalized ratio |
| mean_arterial_pressure | float | Yes | Mean arterial pressure(mmHg) |
| vasopressors | string | Yes | Patient on vasopressors |
| respiratory_ratio_type | string | Yes | Type of respiratory ratio available |
| respiratory_ratio_value | float | Yes | PaO2/FiO2 or SpO2/FiO2 ratio value |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–45 | Low Risk | Lower mortality risk |
| 45–65 | Moderate Risk | Moderate mortality risk |
| 65–70 | High Risk | High mortality risk |
| 70–100 | Critical Risk | Critical mortality risk |
Evidence-Based References (EBM)
- Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, Durand F, Angeli P, Caraceni P, Hopf C, Alessandria C, Rodriguez E, Solis-Muñoz P, Laleman W, Trebicka J, Zeuzem S, Gustot T, Mookerjee R, Elkrief L, Soriano G, Cordoba J, Morando F, Gerbes A, Agarwal B, Samuel D, Bernardi M, Arroyo V; CANONIC study investigators of the EASL-Clif Consortium. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61(5):1038-47.
- Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL-Clif Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426-37.